Intercept Pharmaceuticals, Inc.

ICPT · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$50,517$84,709$58,151$70,055
Short-Term Investments$435,049$334,980$411,516$582,567
Receivables$26,862$47,617$41,549$38,044
Inventory$0$0-$68,571$8,462
Other Curr. Assets$22,356$25,286$27,022$25,924
Total Curr. Assets$540,127$502,292$477,170$721,315
Property Plant & Equip (Net)$987$9,496$18,653$18,448
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$12,597$15,235$84,666$15,123
Total NC Assets$13,584$24,731$103,319$33,571
Other Assets$0$0$0$0
Total Assets$553,711$527,023$580,489$754,886
Liabilities
Payables$14,234$18,132$24,594$18,975
Short-Term Debt$109,569$3,042$7,248$6,456
Tax Payable$3,144$0$0$0
Deferred Revenue$0$136,691$138,292$130,535
Other Curr. Liab.$106,274$8,952$8,942$6,039
Total Curr. Liab.$230,077$166,817$179,076$162,005
LT Debt$223,104$544,168$568,266$532,078
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,453$0$0$9,247
Total NC Liab.$230,557$544,168$568,266$541,325
Other Liabilities$0$0$0$0
Cap. Leases$0$7,428$14,932$6,456
Total Liabilities$460,634$710,985$747,342$703,330
Equity
Pref Stock$0$0$0$0
Common Stock$42$30$33$33
Retained Earnings-$2,136,888-$2,489,772-$2,398,346-$2,123,466
AOCI-$8,256-$2,873-$2,477-$1,144
Other Equity$2,238,179$2,308,653$2,233,937$2,176,133
Total Equity$93,077-$183,962-$166,853$51,556
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$553,711$527,023$580,489$754,886
Net Debt$282,156$462,501$517,363$468,479